Patent · US Active

Anti-HER2 vaccine based upon AAV derived multimeric structures

US9821043B2 · kind B2 · utility

0Cited by

2References

35Claims

0Family size

Assignee

Medi&Gene Inc. · DE

Inventors

Uwe Michaelis · Darmstadt, DE
Erika Jensen-Jarolim · Wien, AT
Christoph Rehfuess · Birkenfeld, DE
Margit Weghofer · Wien, AT

Key dates

Filing date	Sep 14, 2012
Grant date	Nov 21, 2017
Priority date	—
Expiry date	Oct 20, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2984
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.